Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Apr;21(4):262-4.

[Study on Effect of Moxibustion and Guben Yiliu III Combined With Chemotherapy in Treating Middle-Late Stage Malignant Tumor]

[Article in Chinese]
Affiliations
  • PMID: 12577352
Clinical Trial

[Study on Effect of Moxibustion and Guben Yiliu III Combined With Chemotherapy in Treating Middle-Late Stage Malignant Tumor]

[Article in Chinese]
J Liu et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. .

Abstract

Objective: To observe the complementary function of moxibustion and Guben Yiliu III (GBYL), a Chinese herbal composite preparation, in combination with chemotherapy.

Methods: Eighty-one patients of middle-late stage malignant tumor were randomly divided into three groups, 16 in the control group treated with chemotherapy alone, 35 in the TCM group treated with chemotherapy combined GBYL and 30 in the TCM combined moxibustion group. The therapeutic effect of treatment was evaluated according to the immediate effect, living quality scoring, etc.

Results: The comprehensive living quality score and Karnofsky score dropped significantly in the control group after treatment with significant increase of pain score and decrease of tongue figure score (P < 0.05 or P < 0.01). In the TCM group, the former two criteria lowered less than those in the control group, but no significant difference in the latter two criteria was shown. For those in the TCM combined moxibustion group, all the four criteria were improved better than those in the control group (P < 0.01 or P < 0.05).

Conclusion: GBYL combined or not combined with moxibustion could improve the living quality of patients received chemotherapy.

Similar articles

See all similar articles

Cited by 3 articles

Supplementary concepts

LinkOut - more resources

Feedback